Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer
NCT01972737
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Colon Cancer
Interventions
BIOLOGICAL:
Ad5-hGCC-PADRE vaccine
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University